cancer drugs PhD Projects, Programmes & Scholarships

We have 68 cancer drugs PhD Projects, Programmes & Scholarships

Immune-dysregulation in chronic inflammatory muco-cutaneous disorders

Aberdeen University School of Medicine, Medical Sciences & Nutrition

This exciting PhD project provides a rare opportunity to discover novel mechanisms of immune-dysregulation in under-researched but clinically important… Read more

Supervisors: Prof K Hijazi, Dr R Abu Eid, Prof D J Blackbourn

18 May 2024 PhD Research Project Funded PhD Project (Students Worldwide)

More Details

Last chance to apply

Understanding the benefits and risks of the therapeutic targeting of the Nrf2 stress response

University of Liverpool Institute of Systems, Molecular and Integrative Biology

This studentship is fully funded for 4 years and is due to start in October 2024. Important. the tuition fee element of the studentship covers the fee rate for UK students only. Read more

Supervisor: Prof I Copple

19 April 2024 PhD Research Project Funded PhD Project (UK Students Only)

More Details

Defining the molecular mechanisms of leukaemia chemotherapies

The University of Manchester Faculty of Biology, Medicine and Health

Chemotherapies are usually the backbone of cancer treatment for either curative or palliative patient care. Multiple therapies can be used for the same disease, with the choice of drug dependent on parameters such as the patient’s age and fitness. Read more

Supervisors: Dr JK Knight, Dr K Batta, Dr D Wiseman

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Translational Medicine: Understanding the mechanism(s) of resistance to EPA to personalise therapy and improve outcome

University of Leeds Faculty of Medicine and Health

Advanced colorectal cancer (CRC) is the UK’s second most lethal cancer, with limited treatment options for unresectable metastatic tumours. Read more

Supervisors: Dr MA Volpato, Prof M Hull

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

(University of Manchester - University of Tokyo Dual Award) Diversifying Antitumor Drugs through the Integration of Synthetic Biology and Chemo-enzymatic Approaches

The University of Manchester Department of Chemistry

Ecteinascidin 743 (ET-743, Trabectedin) is a marine-derived natural organic compound approved for the treatment of soft tissue sarcomas. Read more

Supervisors: Prof E Takano, Prof H Oguri

29 April 2024 PhD Research Project Funded PhD Project (Students Worldwide)

More Details

Design and synthesis of next-generation antibody drug conjugates to target homologous recombination deficient cancers

University of Strathclyde Department of Pure and Applied Chemistry

Background. Antibody-drug conjugates (ADCs) offer a powerful strategy for the cell-selective delivery of therapeutics, while minimizing off-target interactions associated with the drug payload. Read more

Supervisors: Prof G Burley, Dr Z Rattray

3 May 2024 PhD Research Project Funded PhD Project (Students Worldwide)

More Details

Studying protein homeostasis in healthy and malignant stem cells

University of York York Biomedical Research Institute

This PhD will focus on studying the protein biology of healthy and malignant stem cells of the blood system. Read more

Supervisors: Dr W Grey, Prof D G Kent

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Development of tumor on a chip models for novel therapy evaluation

University of Adelaide School of Chemical Engineering

Project. Cancer is a complex and multifaceted disease, and the development of effective treatments remains a significant challenge. Read more

Supervisor: Prof CXZ Zhao

Year round applications PhD Research Project Funded PhD Project (Students Worldwide)

More Details

Molecular Glues as Novel Tools for Tackling Big Challenges in Human Health

University of Leicester Department of Chemistry

Background. The need for new medicines is greater than ever because of an ageing population and the complex clinical challenges brought about by drug resistance and/or side effects. Read more

Supervisors: Dr RD Doveston, Prof S Macip

23 May 2024 PhD Research Project Competition Funded PhD Project (UK Students Only)

More Details

How does the E5 oncoprotein contribute to human papillomavirus replication and disease?

University of Leeds Faculty of Biological Sciences

The School of Molecular and Cellular Biology invites applications from prospective postgraduate researchers who wish to commence study for a PhD in the academic year 2024/25. Read more

Supervisors: Dr A Macdonald, Prof A Whitehouse

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Using chemical-genetics to inhibit and characterise “undruggable” enzymes

University of Dundee School of Medicine

The ability to inhibit kinases with small molecule drugs has transformed our understanding of signalling networks. It has allowed us to define the substrates and processes that each kinase controls, and to map how these enzymes cooperate within signalling pathways. Read more

Supervisors: Dr A Saurin, Dr T Ly

30 June 2024 PhD Research Project Self-Funded PhD Students Only

More Details

Pharmacokinetics Guided Natural Products Exploration for Drug Discovery, Development, Delivery and Therapy

University of Bradford Faculty of Life Sciences

Research Group: Institute of Cancer Therapeutics

Natural products have emerged as a key standard in novel and safe delivery of anticancer bioactive compounds. Apart from their ease of administration and delivery, natural/phytochemicals still face several hurdles, due to their physiochemical and pharmacokinetic properties. Read more

Supervisor: Dr Muhammad Wahajuddin

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Structure-based design of allosteric modulators for G protein-coupled receptors using molecular modelling and pharmacology experiments

Queen’s University Belfast School of Pharmacy

Almost all physiological processes are regulated through the activation of G protein-coupled receptors (GPCRs). It has become widely accepted that most GPCRs possess binding sites spatially distinct from their natural ligand binding site (orthosteric site), termed as allosteric sites. Read more

Supervisors: Dr I Tikhonova, Dr B Plouffe

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Investigating local invasion in primary and secondary brain tumours

University of Liverpool Department of Molecular and Clinical Cancer Medicine

Brain tumours are highly invasive and carry a poor prognosis. Secondary brain tumours or brain metastases (BM) are the most common tumours found in the brain affecting up to one third of patients with solid organ cancer. Read more

Supervisor: Dr RZ Zakaria

2 December 2024 PhD Research Project Self-Funded PhD Students Only

More Details

Expanding the ligandable E3 ubiquitin ligases for targeted protein degradation

University of Dundee School of Life Sciences

Out of more than 600 E3 ubiquitin ligases in cells, currently only a handful have small molecule binders that can be used for PROteolysis Targeting Chimeras (PROTACs) and harnessed for targeted protein degradation. Read more

Supervisors: Prof G Sapkota, Dr S Virdee

30 June 2024 PhD Research Project Self-Funded PhD Students Only

More Details

We have 68 cancer drugs PhD Projects, Programmes & Scholarships

cancer drugs PhD Projects, Programmes & Scholarships

We have 68 cancer drugs PhD Projects, Programmes & Scholarships

Select your nearest city

Do you want hassle-free information and advice?